Skip to content

Safety and efficacy of transcutaneous vagus nerve electrical stimulation for promoting postoperative rehabilitation in patients undergoing weight loss surgery: A single-center, prospective, randomized controlled study

Safety and efficacy of transcutaneous vagus nerve electrical stimulation for promoting postoperative rehabilitation in patients undergoing weight loss surgery: A single-center, prospective, randomized controlled study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500101092
Enrollment
Unknown
Registered
2025-04-21
Start date
2025-04-21
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Interventions

Sponsors

Drum Tower Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Bariatric surgery patients; 2.ASA ?-?; 3.Subjects voluntarily participated in this study and signed an informed consent form;

Exclusion criteria

Exclusion criteria: 1.Reluctant to participate in enrollment and incapable of completing the trial plan; 2.The skin exhibited signs of damage, redness, swelling, and infection at the site intended for transcutaneous vagal electrical stimulation; 3.The patient experienced tinnitus and arrhythmia preoperatively; 4.The patient equipped with artificial devices, such as pacemakers; 5.Alcohol or drug dependence; 6.Preoperative history of psychiatric disorders, epilepsy, Parkinson's disease, or myasthenia gravis; 7.Preoperative inability to communicate for any reason; 8.Preoperative LVEF <30%; preoperative sick sinus syndrome, severe sinus bradycardia (heart rate <50 bpm), or second-degree or higher atrioventricular block without pacemaker implantation; 9.Severe hepatic dysfunction (Child-Pugh class C); 10.Severe renal dysfunction (preoperative dialysis therapy); 11.Current participation in other clinical trials; 12.Other investigator-determined exclusion criteria;

Design outcomes

Primary

MeasureTime frame
Postoperative nausea and vomiting;

Secondary

MeasureTime frame
Postoperative pain situation;Postoperative recovery quality QOR-15;IL-6;Anxiety score;First Anal Ventilation;Postoperative fatigue score;TNF-a;Post-operative length of stay;IL-1;Postoperative delirium;Sleep quality score;Depression score;

Countries

China

Contacts

Public ContactGu Xiaoping/Zang Ting

Drum Tower Hospital

asdfghjklpoiu@2767.com+86 13776520089

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026